BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for Feb. 23, 2023

Feb. 23, 2023
Med-tech firms raising money in public or private financings, including: Exact Sciences.
Read More

Financings for Feb. 23, 2023

Feb. 23, 2023
Biopharmas raising money in public or private financings, including: Abivax, Apellis, Aprea, Omega, Transcend.
Read More
A microscopic image of liver tissue affected by metabolic dysfunction-associated steatotic liver disease.
Endocrine/Metabolic

Seed funding at Resalis to support development of ncRNA-based therapeutics for metabolic disease

Feb. 23, 2023
Resalis Therapeutics Srl has completed a seed financing round of €10 million (US$10.6 million) to establish a noncoding RNA (ncRNA)-based...
Read More
Creo medical products

Creo Medical fund raise plugs gap, eases investors’ concerns

Feb. 22, 2023
By Shani Alexander
Creo Medical Group plc is on its way to being cash flow breakeven and profitable following a successful fundraise, which will accelerate the rollout of its suite of electrosurgical products, CEO Craig Gulliford told BioWorld.
Read More

Financings for Feb. 22, 2023

Feb. 22, 2023
Med-tech firms raising money in public or private financings, including: Bellevue Life Sciences, Current Surgical.
Read More

Financings for Feb. 22, 2023

Feb. 22, 2023
Biopharmas raising money in public or private financings, including: Abilita, Apellis, Azitra, Biomx, Quoin, Sorrento.
Read More
Previa Medical - SEPSIS SCORE platform

Previa raises funds for early sepsis detection software

Feb. 21, 2023
By Shani Alexander
Previa Medical SA will begin clinical trials later this year of its artificial intelligence software designed for early detection of sepsis after it raised €2.1 million (US $2.2 million) in seed funds.
Read More

Hemab, ‘an Alexion five years from now,’ closes $135M series B

Feb. 21, 2023
By Cormac Sheridan
Hemab Therapeutics ApS raised $135 million in a series B funding round to continue its broad effort to build a company focused on developing prophylactic therapies for neglected bleeding and thrombotic disorders. The new cash brings its total equity raise to $190 million.
Read More

Financings for Feb. 21, 2023

Feb. 21, 2023
Biopharmas in Asia-Pacific raising money in public or private financings: Glycomimetics.
Read More

Financings for Feb. 21, 2023

Feb. 21, 2023
Med-tech firms raising money in public or private financings, including: Mirion Technologies, Xeltis.
Read More
Previous 1 2 … 284 285 286 287 288 289 290 291 292 … 652 653 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 12, 2025.
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing